Search results
Showing results for
We are looking for healthy adults to take part in the initial trial of a potential new vaccine against a virus considered to be a crucial missing element in the childhood vaccination programme. **Please note, this study has recruited a sufficient number of participants**
Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.
Journal article
Abuga KM. et al, (2027), Lancet Glob Health
Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.
Journal article
Firth C. et al, (2026), Hum Vaccin Immunother, 22
The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.
Journal article
Kazungu Y. et al, (2026), Virulence, 17
Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.
Journal article
Monk V. et al, (2026), Expert Rev Vaccines, 25
What is unhealthy about public health? Vaccination, evidence and the politics of uncertainty
Journal article
Mezza M. and Vanderslott S., (2026), Humanities and Social Sciences Communications, 13
Accurately modeling RNase H-mediated antisense oligonucleotide efficacy.
Journal article
Hill B. et al, (2026), Mol Ther Nucleic Acids, 37
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.
Journal article
Prunotto G. et al, (2026), J Hum Immun, 2
Timing matters: Exon skipping therapy is most effective when initiated early in a mouse model of Duchenne muscular dystrophy
Journal article
Stenler S. et al, (2026), Molecular Therapy Nucleic Acids, 37, 103017 - 103017
Muscle MRI as an Imaging Biomarker of Muscle Damage in Patients With Spinal and Bulbar Muscular Atrophy.
Journal article
Grunseich C. et al, (2026), Neurology, 107
Ly6d expression delineates two putative postnatal thymus epithelial progenitor cells that are differentially affected by aging.
Journal article
Calvo-Asensio I. et al, (2026), Sci Adv, 12
Impact of dosing interval on immunogenicity following a heterologous typhoid conjugate vaccine booster in Nepalese children: an observational study.
Journal article
Zhang Y. et al, (2026), J Infect
Measles in Ugandan Children Under 18 Months of Age: A Retrospective Study of Case-based Surveillance, 2018-2024.
Journal article
Businge GB. et al, (2026), Open Forum Infect Dis, 13
COVID-19 vaccine effectiveness and SARS-CoV-2 variants in Nepal: Test-negative case-control study and genetic sequencing (COVVAR Nepal)
Journal article
Pokhrel B. et al, (2026), Vaccine X, 31
To screen or not to screen G6PD deficiency in gNBS: insights from the BabyDetect pilot and current evidence.
Journal article
Jacquemin V. et al, (2026), Eur J Hum Genet
The Thrombopoietin Receptor S264F Mutant Drives MPN with Marrow Fibrosis Through a Dual Mechanism
Journal article
MEAD A., (2026), HemaSphere
MT‐RNR1 genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)
Journal article
McDermott JH. et al, (2026), British Journal of Clinical Pharmacology
Typhoid Seroepidemiology for TCV Decision‑Making Meeting Report of the 18 July 2025 Expert Consultation
Preprint
Laurens M. et al, (2026)
Correction: Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.
Journal article
Dobutr T. et al, (2026), Sci Rep, 16
The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome.
Journal article
Boucher AC. et al, (2026), Leukemia
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
Journal article
Ebrahimi N. et al, (2026), Vaccine, 88